IL10 and hepatocellular carcinoma: However, our results are in agreement with those of Shakiba et al. [48] and El-Emshaty et al. [49], who reported significantly upregulated serum levels of IL-10 and IL-12 in patients with chronic liver disease, suggesting that persistent chronic inflammation is associated with HCC risk.